Study of Difluprednate vs. Prednisolone Acetate on Visual Acuity, and Corneal Edema Following Cataract Surgery.

PHASE4CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

June 30, 2010

Study Completion Date

November 30, 2010

Conditions
CataractsCorneal EdemaRetinal Structural Change, Deposit and DegenerationVisual Acuity Reduced Transiently
Interventions
DRUG

Difluprednate ophthalmic emulsion 0.05%

Difluprednate ophthalmic emulsion 0.05%: 29 days total, total of 7 drops prior to surgery, and 3 more following surgery while at the surgery center, then Q2H on day of surgery, then QID for 1 week, then BID for 1 week, then stop.

DRUG

Prednisolone acetate 1%

Prednisolone acetate 1% : 29 days total, total of 7 drops prior to surgery, and 3 more following surgery while at the surgery center, then Q2H on day of surgery, then QID for 1 week, then BID for 1 week, then stop.

Trial Locations (3)

11563

Ophthalmic Consultants of Long Island, Lynbrook

29464

Carolina Eyecare, Mt. Pleasant

41017

Cincinnati Eye Institute, Edgewood

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Sirion Therapeutics, Inc.

INDUSTRY

collaborator

Alcon Research

INDUSTRY

collaborator

Parsons Medical Communications

UNKNOWN

lead

Edward J. Holland

OTHER

NCT01244334 - Study of Difluprednate vs. Prednisolone Acetate on Visual Acuity, and Corneal Edema Following Cataract Surgery. | Biotech Hunter | Biotech Hunter